Jim Simons Biomarin Pharmaceutical Inc Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 542,071 shares of BMRN stock, worth $40.7 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
542,071
Previous 386,671
40.19%
Holding current value
$40.7 Million
Previous $37.3 Million
26.99%
% of portfolio
0.07%
Previous 0.06%
Shares
20 transactions
Others Institutions Holding BMRN
# of Institutions
621Shares Held
181MCall Options Held
1.73MPut Options Held
1.73M-
Primecap Management CO Pasadena, CA18.7MShares$1.4 Billion1.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$1.36 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.09 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA14MShares$1.05 Billion0.75% of portfolio
-
State Street Corp Boston, MA6.9MShares$518 Million0.03% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $13.9B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...